Pennsylvania Statutes Title 35 P.S. Health and Safety § 960.22. Definitions

The following words and phrases when used in this act shall have the meanings given to them in this section unless the context clearly indicates otherwise:

“Application programming interface.”A set of tools, definitions and protocols for building and integrating application software and services with different software programs.

“Authorized users.”Law enforcement officers and any other permitted users of the overdose information network, as determined by the Pennsylvania State Police, who are required to report overdoses and suspected overdoses to the network in accordance with this act.

“Information technology platform.”As follows:

(1) The Overdose Information Network (ODIN).

(2) Any other platform approved by the Pennsylvania State Police to capture real-time overdose reporting.

“Law enforcement officer.”A member of the Pennsylvania State Police, a sheriff or deputy sheriff or an individual employed as a police officer who holds a current certificate under 53 Pa.C.S. Ch. 21 Subch. D  1 (relating to municipal police education and training).

“Local leader.”Any of the following:

(1) The chief executive officer of a municipality.

(2) The governing body of a municipality.

(3) The chief law enforcement officer of a municipality.

“Overdose.” As follows:

(1) An acute medical condition, including severe physical illness, coma, mania, hysteria or death, which is the result of consumption or use of one or more controlled substances causing an adverse reaction.

(2) A person's condition shall be deemed an overdose if a prudent layperson would reasonably believe that the condition is in fact a drug overdose and requires immediate medical attention.

“Overdose information network” or “network.”The Statewide overdose mapping and response network established under this act.

“Overdose reversal drug.”A drug or device approved by the Federal Food, Drug, and Cosmetic Act (52 Stat. 1040, 21 U.S.C. § 301 et seq.) for emergency reversal of a known or suspected overdose, including naloxone hydrochloride or other similarly acting drugs approved by the United States Food and Drug Administration.

“Overdose spike.”The occurrence of a significant increase in the number of confirmed or suspected overdoses in a certain time frame within a specific geographic area.